{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:51:30Z","timestamp":1791582690711,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addictive Behaviors Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.abrep.2026.100736","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:09:51Z","timestamp":1787242191000},"page":"100736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["DAST-28 severity and injection-related harm risks among people using psychoactive substances in psychiatric and correctional settings in Mongolia: a multicenter cross-sectional study"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1974-6320","authenticated-orcid":false,"given":"Bilguun","family":"Nyamdorj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5810-7850","authenticated-orcid":false,"given":"Khongorzul","family":"Davaadorj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6236-8727","authenticated-orcid":false,"given":"Tergel","family":"Khuyag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2494-2449","authenticated-orcid":false,"given":"Uranchimeg","family":"Mungunkhuyag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9522-3221","authenticated-orcid":false,"given":"Munkhnaran","family":"Mandakh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7603-2591","authenticated-orcid":false,"given":"Davaalkham","family":"Jagdagsuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8647-8585","authenticated-orcid":false,"given":"Nursabi","family":"Khizatkhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8881-9392","authenticated-orcid":false,"given":"Khishigsuren","family":"Zuunnast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2929-8392","authenticated-orcid":false,"given":"Dariimaa","family":"Ganbat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6032-8863","authenticated-orcid":false,"given":"Oyunsuren","family":"Davaasuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.abrep.2026.100736_bb0005","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.euroneuro.2017.08.430","article-title":"How addictive are gabapentin and pregabalin? A systematic review","volume":"27","author":"Bonnet","year":"2017","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.abrep.2026.100736_bb0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drugalcdep.2014.08.005","article-title":"Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications","volume":"144","author":"Castaneto","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.abrep.2026.100736_bb0015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1037\/1040-3590.10.4.408","article-title":"Psychometric properties of the drug abuse screening test in psychiatric outpatients","volume":"10","author":"Cocco","year":"1998","journal-title":"Psychological Assessment"},{"issue":"10049","key":"10.1016\/j.abrep.2026.100736_bb0020","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(16)30466-4","article-title":"Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees","volume":"388","author":"Dolan","year":"2016","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.abrep.2026.100736_bb0025","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2975\/27.2004.360.374","article-title":"A review of treatments for people with severe mental illnesses and co-occurring substance use disorders","volume":"27","author":"Drake","year":"2004","journal-title":"Psychiatric Rehabilitation Journal"},{"issue":"9596","key":"10.1016\/j.abrep.2026.100736_bb0030","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"The Lancet"},{"issue":"4","key":"10.1016\/j.abrep.2026.100736_bb0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.abrep.2026.100736_bb0040","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/add.13877","article-title":"Substance use disorders in prisoners: An updated systematic review and meta-regression analysis in recently incarcerated men and women","volume":"112","author":"Fazel","year":"2017","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.abrep.2026.100736_bb0045","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1360-0443.1989.tb03463.x","article-title":"Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders","volume":"84","author":"Gavin","year":"1989","journal-title":"British Journal of Addiction"},{"issue":"10","key":"10.1016\/j.abrep.2026.100736_bb0050","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/add.14234","article-title":"Global statistics on alcohol, tobacco and illicit drug use: 2017 status report","volume":"113","author":"Peacock","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.abrep.2026.100736_bb0055","article-title":"Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs","volume":"9","author":"Platt","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1016\/j.abrep.2026.100736_bb0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0306-4603(82)90005-3","article-title":"The drug abuse screening test","volume":"7","author":"Skinner","year":"1982","journal-title":"Addictive Behaviors"},{"issue":"12","key":"10.1016\/j.abrep.2026.100736_bb0065","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1473-3099(18)30469-9","article-title":"Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: A systematic review and meta-analysis","volume":"18","author":"Stone","year":"2018","journal-title":"The Lancet Infectious Diseases"},{"issue":"1","key":"10.1016\/j.abrep.2026.100736_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2016","journal-title":"Clinical Toxicology"},{"key":"10.1016\/j.abrep.2026.100736_bb0075","series-title":"World Drug Report 2026","author":"United Nations Office on Drugs and Crime","year":"2026"},{"key":"10.1016\/j.abrep.2026.100736_bb0080","series-title":"Needle and syringe programmes for people who inject drugs: Operational guide","author":"World Health Organization","year":"2026"},{"key":"10.1016\/j.abrep.2026.100736_bb0085","series-title":"WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users: 2012 revision","author":"World Health Organization, United Nations Office on Drugs and Crime, & UNAIDS","year":"2012"},{"issue":"2","key":"10.1016\/j.abrep.2026.100736_bb0090","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jsat.2006.08.002","article-title":"A comprehensive review of the psychometric properties of the drug abuse screening test","volume":"32","author":"Yudko","year":"2007","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Addictive Behaviors Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853226000726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352853226000726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:03:07Z","timestamp":1791579787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352853226000726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":18,"alternative-id":["S2352853226000726"],"URL":"https:\/\/doi.org\/10.1016\/j.abrep.2026.100736","relation":{},"ISSN":["2352-8532"],"issn-type":[{"value":"2352-8532","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DAST-28 severity and injection-related harm risks among people using psychoactive substances in psychiatric and correctional settings in Mongolia: a multicenter cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Addictive Behaviors Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abrep.2026.100736","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100736"}}